Source - SMW
Sinclair Pharma said it had received regulatory approval for its Ellansé cosmetic product in Brazil.

Ellansé is a pre-mixed bioresorbable collagen stimulating filler.

The approval means the product can now be 'soft launched' immediately, ahead of a planned full launch at the end of the first quarter, the company said.

At 9:07am: (LON:SPH) Sinclair IS Pharma PLC share price was +0.55p at 23.7p